Biotest Pharmaceuticals relocates its plasma collection center to San Antonio, Texas

Apr 3 2015

Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the relocation of its plasma collection center to 618 NW Loop 410 Suite 101 San Antonio, Texas. The 18,000 square foot state-of-the-art facility officially opened its doors for business on Sunday, March 29^th 2015.

"This facility relocation represents our continued commitment to better serve our donors that help the thousands of patients world-wide that rely on plasma based therapies" said Jordan Siegel, BPC's Chief Executive Officer.

The plasma donated at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas, such as BPC's BIVIGAM^® [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB^® [Hepatitis B Immune Globulin (Human)].

The Company expects this newly relocated facility to expand its current workforce to over 50 employees and currently has employment opportunities available for medical personnel and phlebotomists.

In addition to supporting the local economy through employment opportunities, the plasma center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma derived therapies that save the lives of thousands of patients but also are compensated for their donations.

SOURCE Biotest Pharmaceuticals Corporation